• Profile
Close

Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κB pathway in human colon cancer cell

Cancer Management and Research Evidence based | Oct 17, 2017

Ma J, et al. - In this study, authors searched for the relationship between cancer cells and stromal cells in carcinoma cell living microenvironment and elucidated the mechanism that interleukin-1 receptor antagonist (IL-1RA) blocks metastatic potential in colon cancer. In metastatic process of colon carcinoma cell, IL-1RA proved an important inhibitor. IL-1RA thus seemed a promising new therapeutic approach in inhibiting colon cancer with IL-1-producing patients.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay